AstraZeneca LP v. Hec Pharm Co., Ltd

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Richard G. Andrews · 4,097 cases in index

Docket number

1:15-cv-01041

Cause

35:0145
35 U.S.C. § 145

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

None

Date filed

11/12/2015

Date terminated

08/24/2016

11,768 Patent cases in this court are indexed here.

Parties

• plaintiff · AstraZeneca, LP Pharmaceuticals & Biotechnology · 10349 cases
• defendant · Hec Pharm Co., Ltd · 10 cases

Part of a Larger Litigation Pattern

This is one of 11 Patent cases in our index naming HEC Pharm Co., Ltd — a possible mass-tort or coordinated-litigation cluster.

• Novartis Pharmaceuticals Corporation v. Hec Pharm Co., Ltd
  District Court, D. DelawareFiled 01/11/2023
• Astrazeneca LP v. Hec Pharm Co., Ltd
  District Court, D. New JerseyFiled 11/13/2015
• Astrazeneca Ab v. Hec Pharm Co., Ltd
  District Court, D. New JerseyFiled 08/05/2015
• Boehringer Ingelheim Pharmaceuticals Inc v. Hec Pharm Co., Ltd
  District Court, D. New JerseyFiled 08/04/2015
• Novartis Ag v. Hec Pharm Co. Ltd
  District Court, D. DelawareFiled 02/11/2015
• Eli Lilly and Company v. Hec Pharm Co., Ltd
  District Court, S.D. IndianaFiled 07/07/2014

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is AstraZeneca LP v. Hec Pharm Co., Ltd?

AstraZeneca LP v. Hec Pharm Co., Ltd is a federal patent lawsuit filed on 11/12/2015 in the District Court, D. Delaware. The case was terminated on 08/24/2016. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:15-cv-01041.

When was the case filed?

AstraZeneca LP v. Hec Pharm Co., Ltd was filed on 11/12/2015. It was terminated on 08/24/2016.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 145.